Regulatory Post-Marketing Surveillance of Xolair® for Chronic Rhinosinusitis With Nasal Polyps
Clinical trial NCT05626257 · COMPLETED
Trial details
- NCT number
- NCT05626257
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-12
- Primary completion
- 2025-04-15
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.